hsc70 antibody Search Results


91
StressMarq rabbit anti hsc70 antibody
(a) In vivo evidence for <t>Hsc70-Cx43</t> interaction. SDS-PAGE and Coomassie staining of proteins obtained in co-immunoprecipitation assay with anti-Cx43 antibodies using lysates prepared from HuH-7 cells. Arrows indicate the positions of Hsc70 and β-tubulin. Both proteins were identified by MALDI/Q-TOF mass spectrometry analysis. (b) Binding of Hsc70 to GST-Cx43CT. Proteins extracted from HuH-7 cells were mixed either with GST or with GST-Cx43CT residues 228-382 resin. After washing, the bound proteins were released and analyzed on 12% SDS-PAGE followed by western blotting (WB) with anti-Hsc70 antibody. Full-length blots are presented in . (c and d) Co-immunoprecipitation of Hsc70 with Cx43. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and T7-tagged Hsc70 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-Cx43 antibodies and control IgG (c) or by anti-T7 antibody and the IgG (d). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody (c) or anti-Cx43 antibodies (d). Full-length blots are presented in . (e) Co-localization of endogenous Hsc70 and Cx43. HuH-7 cells were fixed and stained with anti-Cx43 antibodies and anti-Hsc70 antibody. The nuclei were stained with TO-PRO3. Co-localization of both proteins was observed in the cytoplasm.
Rabbit Anti Hsc70 Antibody, supplied by StressMarq, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti hsc70 antibody/product/StressMarq
Average 91 stars, based on 1 article reviews
rabbit anti hsc70 antibody - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

94
Novus Biologicals heat shock protein hsp 72
(a) In vivo evidence for <t>Hsc70-Cx43</t> interaction. SDS-PAGE and Coomassie staining of proteins obtained in co-immunoprecipitation assay with anti-Cx43 antibodies using lysates prepared from HuH-7 cells. Arrows indicate the positions of Hsc70 and β-tubulin. Both proteins were identified by MALDI/Q-TOF mass spectrometry analysis. (b) Binding of Hsc70 to GST-Cx43CT. Proteins extracted from HuH-7 cells were mixed either with GST or with GST-Cx43CT residues 228-382 resin. After washing, the bound proteins were released and analyzed on 12% SDS-PAGE followed by western blotting (WB) with anti-Hsc70 antibody. Full-length blots are presented in . (c and d) Co-immunoprecipitation of Hsc70 with Cx43. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and T7-tagged Hsc70 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-Cx43 antibodies and control IgG (c) or by anti-T7 antibody and the IgG (d). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody (c) or anti-Cx43 antibodies (d). Full-length blots are presented in . (e) Co-localization of endogenous Hsc70 and Cx43. HuH-7 cells were fixed and stained with anti-Cx43 antibodies and anti-Hsc70 antibody. The nuclei were stained with TO-PRO3. Co-localization of both proteins was observed in the cytoplasm.
Heat Shock Protein Hsp 72, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/heat shock protein hsp 72/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
heat shock protein hsp 72 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology actin sc 1615
(a) In vivo evidence for <t>Hsc70-Cx43</t> interaction. SDS-PAGE and Coomassie staining of proteins obtained in co-immunoprecipitation assay with anti-Cx43 antibodies using lysates prepared from HuH-7 cells. Arrows indicate the positions of Hsc70 and β-tubulin. Both proteins were identified by MALDI/Q-TOF mass spectrometry analysis. (b) Binding of Hsc70 to GST-Cx43CT. Proteins extracted from HuH-7 cells were mixed either with GST or with GST-Cx43CT residues 228-382 resin. After washing, the bound proteins were released and analyzed on 12% SDS-PAGE followed by western blotting (WB) with anti-Hsc70 antibody. Full-length blots are presented in . (c and d) Co-immunoprecipitation of Hsc70 with Cx43. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and T7-tagged Hsc70 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-Cx43 antibodies and control IgG (c) or by anti-T7 antibody and the IgG (d). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody (c) or anti-Cx43 antibodies (d). Full-length blots are presented in . (e) Co-localization of endogenous Hsc70 and Cx43. HuH-7 cells were fixed and stained with anti-Cx43 antibodies and anti-Hsc70 antibody. The nuclei were stained with TO-PRO3. Co-localization of both proteins was observed in the cytoplasm.
Actin Sc 1615, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/actin sc 1615/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
actin sc 1615 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti hsc70 sc 7298
(a) In vivo evidence for <t>Hsc70-Cx43</t> interaction. SDS-PAGE and Coomassie staining of proteins obtained in co-immunoprecipitation assay with anti-Cx43 antibodies using lysates prepared from HuH-7 cells. Arrows indicate the positions of Hsc70 and β-tubulin. Both proteins were identified by MALDI/Q-TOF mass spectrometry analysis. (b) Binding of Hsc70 to GST-Cx43CT. Proteins extracted from HuH-7 cells were mixed either with GST or with GST-Cx43CT residues 228-382 resin. After washing, the bound proteins were released and analyzed on 12% SDS-PAGE followed by western blotting (WB) with anti-Hsc70 antibody. Full-length blots are presented in . (c and d) Co-immunoprecipitation of Hsc70 with Cx43. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and T7-tagged Hsc70 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-Cx43 antibodies and control IgG (c) or by anti-T7 antibody and the IgG (d). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody (c) or anti-Cx43 antibodies (d). Full-length blots are presented in . (e) Co-localization of endogenous Hsc70 and Cx43. HuH-7 cells were fixed and stained with anti-Cx43 antibodies and anti-Hsc70 antibody. The nuclei were stained with TO-PRO3. Co-localization of both proteins was observed in the cytoplasm.
Anti Hsc70 Sc 7298, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hsc70 sc 7298/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
anti hsc70 sc 7298 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Proteintech hsc70
Fig. 2. Signaling networks associated with the differentially expressed proteins. To identify the signal transduction pathways and/or signaling networks associated with the differentially expressed proteins, the 73 identified proteins were imported into the MINT, HPRD, and GRID databases. Yellow spots represent the target proteins with a known regulatory relationship. Red spots represent the interacting proteins. (A) Twenty-nine target proteins of the total 73 proteins were used to constructing the protein interaction network shown. (B) MAP4K1, MAP4K5, MAPK1, MAPK3, and <t>Hsc70</t> (HSPA8) were present in the protein interaction network. (C) Flow chart describing the relationships between members of the MAPK pathway.
Hsc70, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hsc70/product/Proteintech
Average 96 stars, based on 1 article reviews
hsc70 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Proteintech rabbit anti stip1 antibody
(A–C) Degradation assay in immunofluorescence against Ca V 1.2 (A) and Ca V 2.3 (B) of primary beta cells of the indicated genotypes after the CHX treatment of the indicated periods; accompanied by their quantification along with that of α-tubulin (C). Bars, 5 μm. * p < 0.05, *** p < 0.001, Welch’s t test at the indicated time; n = 6 (Ca V 1.2), 17–24 (Ca V 2.3), 5–6 (α-tubulin). (D and E) Brefeldin-A (BFA) washout assay with an LSM 5LIVE-Duo microscope, assessing the speeds of post-Golgi trafficking of Ca V 1.2-EGFP proteins expressed in primary beta cells of the indicated genotypes (D), accompanied by its quantification (E). Time after BFA washout is indicated. Bar, 5 μm. *p < 0.05, Welch’s t test, n = 11. Arrows, the timing of plasma membrane fusion. Corresponding to Movie EV4. (F) TIRF/STORM microscopy of a wild-type primary mouse beta cell immunolabeled against Ca V 1.2 and KIF5B. Scale bar, 5 μm. Arrows, colocalizing spots. (G) TIRF/STORM microscopy of primary mouse beta cells of the indicated genotypes immunolabeled against Ca V 1.2 (green) and Ca V 2.3 (magenta). Scale bars, 5 μm. (H) Schematic representation of <t>STIP1-dependent</t> Hsp70-to-Hsp90 chaperone exchange machinery. (I and J) z -projection of proximity ligation assay in CT and cKO primary beta cells showing the protein binding between Ca V 1.2 and the indicated Hsp proteins (I); accompanied by quantification (J). ** p < 0.01; *** p < 0.001; Welch’s t test, n = 6. (K) Immunoblotting of scramble control (SC) and STIP1-knockdown (KD) MIN6 cells against the indicated epitopes. Note that STIP1 deficiency induced downregulation of Ca V 1.2 and BK Ca proteins. Reproduced twice.
Rabbit Anti Stip1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti stip1 antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti stip1 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Boster Bio hspa8
<t>HSPA8</t> is a target of LACTB. A. qRT-PCR testing the effects of LACTB overexpression and knockout on HSPA8 mRNA levels. B. Western blot testing the indicated protein levels after LACTB overexpression in SK-HEP-1 cells. C. Western blot testing the indicated protein levels in LACTB −/− cells reexpressing LACTB. D. Western blot testing the indicated protein levels in LACTB-expressing cells transfected with HSPA8-expressing plasmid. E. Western blot testing the indicated protein levels in LACTB −/− cells transfected with si-HSPA8. F–I. Detection of effects of LACTB overexpression or in combination with HSPA8 overexpression on Fe 2+ , lipid peroxidation, MDA levels and GSH/GSSG ratio in cells. Scale bar = 25 μm. J,K. Detection of effects of LACTB knockout or in combination with HSPA8 silencing on Fe 2+ and lipid peroxidation levels in HepG2 and SK-HEP-1 cells. Scale bar = 25 μm. L. Kaplan-Meier plotter database showing the overall survival rate of liver cancer patients with high or low HSPA8 expression. M. Xenograft tumour model testing the in vivo effects of LACTB or LACTB + HSPA8 on SK-HEP-1 cell growth. Scale bar = 1 cm. Student's t -test was used for A (left panel), one-way ANOVA with Tukey post-hoc test was used for A (right panel), F–K, M (right panel), and two-way ANOVA with Tukey post-hoc test was used for M (middle panel).
Hspa8, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hspa8/product/Boster Bio
Average 93 stars, based on 1 article reviews
hspa8 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Bioss anti heat 334 shock protein a8
<t>HSPA8</t> is a target of LACTB. A. qRT-PCR testing the effects of LACTB overexpression and knockout on HSPA8 mRNA levels. B. Western blot testing the indicated protein levels after LACTB overexpression in SK-HEP-1 cells. C. Western blot testing the indicated protein levels in LACTB −/− cells reexpressing LACTB. D. Western blot testing the indicated protein levels in LACTB-expressing cells transfected with HSPA8-expressing plasmid. E. Western blot testing the indicated protein levels in LACTB −/− cells transfected with si-HSPA8. F–I. Detection of effects of LACTB overexpression or in combination with HSPA8 overexpression on Fe 2+ , lipid peroxidation, MDA levels and GSH/GSSG ratio in cells. Scale bar = 25 μm. J,K. Detection of effects of LACTB knockout or in combination with HSPA8 silencing on Fe 2+ and lipid peroxidation levels in HepG2 and SK-HEP-1 cells. Scale bar = 25 μm. L. Kaplan-Meier plotter database showing the overall survival rate of liver cancer patients with high or low HSPA8 expression. M. Xenograft tumour model testing the in vivo effects of LACTB or LACTB + HSPA8 on SK-HEP-1 cell growth. Scale bar = 1 cm. Student's t -test was used for A (left panel), one-way ANOVA with Tukey post-hoc test was used for A (right panel), F–K, M (right panel), and two-way ANOVA with Tukey post-hoc test was used for M (middle panel).
Anti Heat 334 Shock Protein A8, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti heat 334 shock protein a8/product/Bioss
Average 90 stars, based on 1 article reviews
anti heat 334 shock protein a8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

92
StressMarq endogenous hsc70
Co-immunoprecipitation (co-IP) of ChAT with heat shock proteins <t>HSC70,</t> HSP70, and HSP90 is altered by mutation of N-terminal proline-rich motif in ChAT. (A) Immunoblots showing co-IP of ChAT with endogenous HSC70, HSP70 and HSP90 from HEK293 cells expressing either wild-type or P17A/P19A-ChAT. Control cells were transfected with empty vector. Using HEK293 cells, co-IP of P17A/P19A-ChAT with HSP70 (B) , HSP90 (C) and HSC70 (D) , respectively, is greater than that of wild-type ChAT ( *** p ≤ 0.001, Student's t -test, mean ± SEM, n = 4). (E) Co-IP of ChAT with endogenous HSC70 and HSP90 from mouse cholinergic SN56 cells expressing either wild-type or P17A/P19A-ChAT or CMS-related mutant proteins V18M- or A513T-ChAT. Control cells were transfected with empty vector. (F) Using SN56 cells, Co-IP of P17A/P19A-ChAT ( *** p ≤ 0.001) and V18M-ChAT ( * p ≤ 0.05), but not A531T-ChAT, with HSC70 is greater than that of wild-type ChAT (mean ± SEM, n = 5). (G) While there was a trend toward increased HSP90 interaction with P17A/P19A-ChAT ( p = 0.09), no significant differences were observed for HSP90 interaction with mutant ChAT compared to wild-type ChAT in SN56 cells (mean ± SEM, n = 5). Statistical analysis for (F) and (G) was performed by one-way ANOVA with Dunnett's post-hoc test. (H) Detection of in situ interactions of wild-type ChAT with endogenous HSC70 and HSP90 by proximity ligation assay (PLA) in SN56 cells. Formalin-fixed cells were first co-labeled with goat anti-ChAT together with either mouse anti-HSC70 or mouse anti-HSP90 primary antibodies, then incubated with oligonucleotide-linked secondary antibodies. Following DNA ligation and DNA amplification using the Duolink in Situ Orange Kit (Sigma), in situ ChAT-HSP interactions were imaged by confocal microscopy. Positive in situ ChAT-HSP interactions where visualized as fluorescent red dots while nuclei were stained with DAPI (blue). Control cells were either transfected with empty vector or had primary antibodies omitted from the assay (No 1° antibodies). Images are representative of 3 independent experiments; scale bars are 10 μm.
Endogenous Hsc70, supplied by StressMarq, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endogenous hsc70/product/StressMarq
Average 92 stars, based on 1 article reviews
endogenous hsc70 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

92
StressMarq anti djb1
Co-immunoprecipitation (co-IP) of ChAT with heat shock proteins <t>HSC70,</t> HSP70, and HSP90 is altered by mutation of N-terminal proline-rich motif in ChAT. (A) Immunoblots showing co-IP of ChAT with endogenous HSC70, HSP70 and HSP90 from HEK293 cells expressing either wild-type or P17A/P19A-ChAT. Control cells were transfected with empty vector. Using HEK293 cells, co-IP of P17A/P19A-ChAT with HSP70 (B) , HSP90 (C) and HSC70 (D) , respectively, is greater than that of wild-type ChAT ( *** p ≤ 0.001, Student's t -test, mean ± SEM, n = 4). (E) Co-IP of ChAT with endogenous HSC70 and HSP90 from mouse cholinergic SN56 cells expressing either wild-type or P17A/P19A-ChAT or CMS-related mutant proteins V18M- or A513T-ChAT. Control cells were transfected with empty vector. (F) Using SN56 cells, Co-IP of P17A/P19A-ChAT ( *** p ≤ 0.001) and V18M-ChAT ( * p ≤ 0.05), but not A531T-ChAT, with HSC70 is greater than that of wild-type ChAT (mean ± SEM, n = 5). (G) While there was a trend toward increased HSP90 interaction with P17A/P19A-ChAT ( p = 0.09), no significant differences were observed for HSP90 interaction with mutant ChAT compared to wild-type ChAT in SN56 cells (mean ± SEM, n = 5). Statistical analysis for (F) and (G) was performed by one-way ANOVA with Dunnett's post-hoc test. (H) Detection of in situ interactions of wild-type ChAT with endogenous HSC70 and HSP90 by proximity ligation assay (PLA) in SN56 cells. Formalin-fixed cells were first co-labeled with goat anti-ChAT together with either mouse anti-HSC70 or mouse anti-HSP90 primary antibodies, then incubated with oligonucleotide-linked secondary antibodies. Following DNA ligation and DNA amplification using the Duolink in Situ Orange Kit (Sigma), in situ ChAT-HSP interactions were imaged by confocal microscopy. Positive in situ ChAT-HSP interactions where visualized as fluorescent red dots while nuclei were stained with DAPI (blue). Control cells were either transfected with empty vector or had primary antibodies omitted from the assay (No 1° antibodies). Images are representative of 3 independent experiments; scale bars are 10 μm.
Anti Djb1, supplied by StressMarq, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti djb1/product/StressMarq
Average 92 stars, based on 1 article reviews
anti djb1 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

94
Novus Biologicals hsc70
RNAi screening of host factors related to EBOV-trVLP life cycle and further validation and analysis. (A) RNAi silencing analysis of host factors required for the EBOV trVLP life cycle. A 100 μl sample of opti-MEM medium containing 1.4 μl siRNA and 4.5 μl HiPerFect was placed in 24-well plates, and a cell suspension (400 μl) containing 1 × 10 5 cells was added to give a final siRNA concentration of 75 nM. After incubation for 48 h, cells were infected with trVLPs for another 48 h, total RNA was extracted, and the absolute quantity of EBOV RNA was measured using a EBOV nucleic acid test kit. All qRT-PCR experiments were performed in triplicate and repeated three times independently. Cells not transfected with siRNA but infected with trVLPs served as a blank control; cells transfected with isotype siRNA and infected with trVLPs served as a negative control. Eleven siRNAs targeting HSPA1A, HSP90AB1, ARFGAP1, ANXA5, YWHAZ, MAPK11, NTRK1, FLT4, GRP78, MEK2, and <t>HSPA8</t> inhibited trVLP replication effectively. ∗ p < 0.05, ∗∗ p < 0.01. (B) Western blot analysis of each target protein after siRNA transfection. The 11 target proteins were all expressed at much lower levels following transfection with the relevant siRNA. Normal 293T cells and cells transfected with isotype siRNAs served as controls. (C) Characterization of selected networks of candidate host proteins that may be important for regulating the trVLP life cycle. Interactions of the 11 host proteins were assessed using the GeneMANIA interaction database, and their functions were evaluated in association with cytoplasmic vesicle membranes, mitochondrial membranes, mitochondria, antigen binding, the COP9 signalosome, and phospholipid binding.
Hsc70, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hsc70/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
hsc70 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Boster Bio anti hsp90
RNAi screening of host factors related to EBOV-trVLP life cycle and further validation and analysis. (A) RNAi silencing analysis of host factors required for the EBOV trVLP life cycle. A 100 μl sample of opti-MEM medium containing 1.4 μl siRNA and 4.5 μl HiPerFect was placed in 24-well plates, and a cell suspension (400 μl) containing 1 × 10 5 cells was added to give a final siRNA concentration of 75 nM. After incubation for 48 h, cells were infected with trVLPs for another 48 h, total RNA was extracted, and the absolute quantity of EBOV RNA was measured using a EBOV nucleic acid test kit. All qRT-PCR experiments were performed in triplicate and repeated three times independently. Cells not transfected with siRNA but infected with trVLPs served as a blank control; cells transfected with isotype siRNA and infected with trVLPs served as a negative control. Eleven siRNAs targeting HSPA1A, HSP90AB1, ARFGAP1, ANXA5, YWHAZ, MAPK11, NTRK1, FLT4, GRP78, MEK2, and <t>HSPA8</t> inhibited trVLP replication effectively. ∗ p < 0.05, ∗∗ p < 0.01. (B) Western blot analysis of each target protein after siRNA transfection. The 11 target proteins were all expressed at much lower levels following transfection with the relevant siRNA. Normal 293T cells and cells transfected with isotype siRNAs served as controls. (C) Characterization of selected networks of candidate host proteins that may be important for regulating the trVLP life cycle. Interactions of the 11 host proteins were assessed using the GeneMANIA interaction database, and their functions were evaluated in association with cytoplasmic vesicle membranes, mitochondrial membranes, mitochondria, antigen binding, the COP9 signalosome, and phospholipid binding.
Anti Hsp90, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hsp90/product/Boster Bio
Average 90 stars, based on 1 article reviews
anti hsp90 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(a) In vivo evidence for Hsc70-Cx43 interaction. SDS-PAGE and Coomassie staining of proteins obtained in co-immunoprecipitation assay with anti-Cx43 antibodies using lysates prepared from HuH-7 cells. Arrows indicate the positions of Hsc70 and β-tubulin. Both proteins were identified by MALDI/Q-TOF mass spectrometry analysis. (b) Binding of Hsc70 to GST-Cx43CT. Proteins extracted from HuH-7 cells were mixed either with GST or with GST-Cx43CT residues 228-382 resin. After washing, the bound proteins were released and analyzed on 12% SDS-PAGE followed by western blotting (WB) with anti-Hsc70 antibody. Full-length blots are presented in . (c and d) Co-immunoprecipitation of Hsc70 with Cx43. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and T7-tagged Hsc70 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-Cx43 antibodies and control IgG (c) or by anti-T7 antibody and the IgG (d). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody (c) or anti-Cx43 antibodies (d). Full-length blots are presented in . (e) Co-localization of endogenous Hsc70 and Cx43. HuH-7 cells were fixed and stained with anti-Cx43 antibodies and anti-Hsc70 antibody. The nuclei were stained with TO-PRO3. Co-localization of both proteins was observed in the cytoplasm.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) In vivo evidence for Hsc70-Cx43 interaction. SDS-PAGE and Coomassie staining of proteins obtained in co-immunoprecipitation assay with anti-Cx43 antibodies using lysates prepared from HuH-7 cells. Arrows indicate the positions of Hsc70 and β-tubulin. Both proteins were identified by MALDI/Q-TOF mass spectrometry analysis. (b) Binding of Hsc70 to GST-Cx43CT. Proteins extracted from HuH-7 cells were mixed either with GST or with GST-Cx43CT residues 228-382 resin. After washing, the bound proteins were released and analyzed on 12% SDS-PAGE followed by western blotting (WB) with anti-Hsc70 antibody. Full-length blots are presented in . (c and d) Co-immunoprecipitation of Hsc70 with Cx43. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and T7-tagged Hsc70 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-Cx43 antibodies and control IgG (c) or by anti-T7 antibody and the IgG (d). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody (c) or anti-Cx43 antibodies (d). Full-length blots are presented in . (e) Co-localization of endogenous Hsc70 and Cx43. HuH-7 cells were fixed and stained with anti-Cx43 antibodies and anti-Hsc70 antibody. The nuclei were stained with TO-PRO3. Co-localization of both proteins was observed in the cytoplasm.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: In Vivo, SDS Page, Staining, Co-Immunoprecipitation Assay, Mass Spectrometry, Binding Assay, Western Blot, Immunoprecipitation, Transfection, Expressing

(a) A schematic representation of GST-Cx43CT fusion proteins used as a ligand. Consensus protein domains and regions with putative signaling functions are indicated. Abbreviations in Cx43: TM1-4, transmembrane domains 1–4; JM, juxtamembrane domain that binds microtubules; Y265, Src phosphorylation site; PP, proline-rich sequence that binds the SH3 domain of v-Src; DLEI, carboxy-terminal sequence involved in ZO-1 binding. (b) Identification of Hsc70-binding domain in Cx43. Whole cell lysates of HuH-7 cells and various forms of the GST-Cx43CT fusion proteins were used for GST pulldown assays. Binding experiments and western blotting (WB) were carried out as described in . (c) A schematic representation of Hsc70 and its deletion mutants used for overexpression. (d) Identification of Cx43 binding domain in Hsc70. Expression vectors encoding various Hsc70s were transfected into HuH-7 cells, and binding experiments were carried out as described in . The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) A schematic representation of GST-Cx43CT fusion proteins used as a ligand. Consensus protein domains and regions with putative signaling functions are indicated. Abbreviations in Cx43: TM1-4, transmembrane domains 1–4; JM, juxtamembrane domain that binds microtubules; Y265, Src phosphorylation site; PP, proline-rich sequence that binds the SH3 domain of v-Src; DLEI, carboxy-terminal sequence involved in ZO-1 binding. (b) Identification of Hsc70-binding domain in Cx43. Whole cell lysates of HuH-7 cells and various forms of the GST-Cx43CT fusion proteins were used for GST pulldown assays. Binding experiments and western blotting (WB) were carried out as described in . (c) A schematic representation of Hsc70 and its deletion mutants used for overexpression. (d) Identification of Cx43 binding domain in Hsc70. Expression vectors encoding various Hsc70s were transfected into HuH-7 cells, and binding experiments were carried out as described in . The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: Sequencing, Binding Assay, Western Blot, Over Expression, Expressing, Transfection

(a) Hsc70 interacts with cyclin D1 or Cx43. Co-immunoprecipitation of Hsc70 with cyclin D1 or Cx43. Lysates were prepared from HuH-7 cells co-transfected with T7-tagged Hsc70 and cMyc-tagged cyclin D1 or wild-type Cx43 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-cMyc antibody and control IgG (left) or by anti-Cx43 antibodies and the IgG (right). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody. (b) Absence of interaction between cyclin D1 and Cx43. Co-immunoprecipitation of Cx43 with cyclin D1. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and cMyc-tagged cyclin D1 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-cMyc antibody and control IgG (left) or by anti-Cx43 antibodies and the IgG (right). The immunocomplexes were analyzed by western blotting (WB) using anti-Cx43 antibodies (left) or anti-cMyc antibody (right). (c) Competition assay of Cx43 and cyclin D1 for binding with Hsc70. HuH-7 cells were transfected with equivalent plasmids of both T7-tagged Hsc70 and cMyc-tagged cyclin D1, and with increasing amounts of Cx43. Lysates were immunoprecipitated (IP) by anti-T7 antibody. The immunocomplexes were analyzed by western blotting (WB) using anti-T7-tag, anti-Cx43, and anti-cMyc-tag antibodies.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) Hsc70 interacts with cyclin D1 or Cx43. Co-immunoprecipitation of Hsc70 with cyclin D1 or Cx43. Lysates were prepared from HuH-7 cells co-transfected with T7-tagged Hsc70 and cMyc-tagged cyclin D1 or wild-type Cx43 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-cMyc antibody and control IgG (left) or by anti-Cx43 antibodies and the IgG (right). The immunocomplexes were analyzed by western blotting (WB) using anti-T7 antibody. (b) Absence of interaction between cyclin D1 and Cx43. Co-immunoprecipitation of Cx43 with cyclin D1. Lysates were prepared from HuH-7 cells co-transfected with wild-type Cx43 and cMyc-tagged cyclin D1 expression plasmids. Lysates were immunoprecipitated (IP) either by anti-cMyc antibody and control IgG (left) or by anti-Cx43 antibodies and the IgG (right). The immunocomplexes were analyzed by western blotting (WB) using anti-Cx43 antibodies (left) or anti-cMyc antibody (right). (c) Competition assay of Cx43 and cyclin D1 for binding with Hsc70. HuH-7 cells were transfected with equivalent plasmids of both T7-tagged Hsc70 and cMyc-tagged cyclin D1, and with increasing amounts of Cx43. Lysates were immunoprecipitated (IP) by anti-T7 antibody. The immunocomplexes were analyzed by western blotting (WB) using anti-T7-tag, anti-Cx43, and anti-cMyc-tag antibodies.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: Immunoprecipitation, Transfection, Expressing, Western Blot, Competitive Binding Assay, Binding Assay

(a) BrdU incorporation assays were examined in HuH-7 cells. HuH-7 cells were transiently transfected with vectors encoding empty vector EGFP, Hsc70-EGFP, Cx43-EGFP alone, or both Hsc70- and Cx43-EGFP, respectively. Forty-eight hours after transfection, the cells were labeled with bromodeoxyuridine (BrdU) for 2 hr and subsequently fixed and stained with anti-BrdU antibody. Green indicates transfectants, and red indicates BrdU-incorporated cells. (b) The fraction of BrdU-positive cells over total number of transfected cells was determined. The data shown in (b) are means and SDs (error bars) of a representative experiment performed in triplicate at least. * p < 0.01. N.S.; not significant.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) BrdU incorporation assays were examined in HuH-7 cells. HuH-7 cells were transiently transfected with vectors encoding empty vector EGFP, Hsc70-EGFP, Cx43-EGFP alone, or both Hsc70- and Cx43-EGFP, respectively. Forty-eight hours after transfection, the cells were labeled with bromodeoxyuridine (BrdU) for 2 hr and subsequently fixed and stained with anti-BrdU antibody. Green indicates transfectants, and red indicates BrdU-incorporated cells. (b) The fraction of BrdU-positive cells over total number of transfected cells was determined. The data shown in (b) are means and SDs (error bars) of a representative experiment performed in triplicate at least. * p < 0.01. N.S.; not significant.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: BrdU Incorporation Assay, Transfection, Plasmid Preparation, Labeling, Staining

(a) A schematic representation of Hsc70 and its splice variant, Hsc54, used for overexpression. (b) Pulldown assays with GST-Cx43CT fusion protein were performed using lysates prepared from Hsc70- or Hsc54-transfected HuH-7 cells. Expression vectors encoding Hsc70-EGFP and Hsc54-EGFP were transfected into HuH-7 cells, and binding experiments were carried out as described in . The bound proteins were analyzed by western blotting (WB) using anti-GFP antibody. (c) BrdU incorporation assays in HuH-7 cells. HuH-7 cells were transiently transfected with vectors encoding empty vector EGFP, Hsc54-EGFP, Cx43-EGFP alone, or both Hsc54- and Cx43-EGFP, respectively. BrdU incorporation and immunofluorescence staining were carried out as described in . (d) The fraction of BrdU-positive cells over total number of transfected cells. (e) Inhibition assay of protein-protein interaction. To inhibit the binding of proteins to Hsc70, HuH-7 cells were cultured with 10 μg/ml of 15-DSG for 24 hr. The fraction of BrdU-positive cells over total cells was determined. The data shown in (d) and (e) are means and SDs (error bars) of a representative experiment performed in triplicate at least. * p < 0.01. N.S.; not significant.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) A schematic representation of Hsc70 and its splice variant, Hsc54, used for overexpression. (b) Pulldown assays with GST-Cx43CT fusion protein were performed using lysates prepared from Hsc70- or Hsc54-transfected HuH-7 cells. Expression vectors encoding Hsc70-EGFP and Hsc54-EGFP were transfected into HuH-7 cells, and binding experiments were carried out as described in . The bound proteins were analyzed by western blotting (WB) using anti-GFP antibody. (c) BrdU incorporation assays in HuH-7 cells. HuH-7 cells were transiently transfected with vectors encoding empty vector EGFP, Hsc54-EGFP, Cx43-EGFP alone, or both Hsc54- and Cx43-EGFP, respectively. BrdU incorporation and immunofluorescence staining were carried out as described in . (d) The fraction of BrdU-positive cells over total number of transfected cells. (e) Inhibition assay of protein-protein interaction. To inhibit the binding of proteins to Hsc70, HuH-7 cells were cultured with 10 μg/ml of 15-DSG for 24 hr. The fraction of BrdU-positive cells over total cells was determined. The data shown in (d) and (e) are means and SDs (error bars) of a representative experiment performed in triplicate at least. * p < 0.01. N.S.; not significant.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: Variant Assay, Over Expression, Transfection, Expressing, Binding Assay, Western Blot, BrdU Incorporation Assay, Plasmid Preparation, Immunofluorescence, Staining, Inhibition, Cell Culture

(a) Hsc70 translocated into the nucleus under heat shock. HuH-7 cells were heat shocked at 42°C for 2 hr and stained with anti-Hsc70 antibodies. (b) Overexpression of Cx43 prevented the nuclear translocation of Hsc70 under heat shock. HuH-7 cells were transfected with control vector EGFP or Cx43-EGFP. Forty-eight hours after transfection followed by heat shocked at 42°C for 2 hr, cells were stained with anti-Hsc70 antibodies. (c) Ratio of nuclear/cytoplasmic (N/C) fluorescence intensities in Hsc70. After heat shock, at least 30 transfected HuH-7 cells of control EGFP or Cx43-EGFP were examined and quantified by confocal scanning microscopy. The data shown in (b) were plotted. The horizontal lines represent mean values. * p < 0.01.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) Hsc70 translocated into the nucleus under heat shock. HuH-7 cells were heat shocked at 42°C for 2 hr and stained with anti-Hsc70 antibodies. (b) Overexpression of Cx43 prevented the nuclear translocation of Hsc70 under heat shock. HuH-7 cells were transfected with control vector EGFP or Cx43-EGFP. Forty-eight hours after transfection followed by heat shocked at 42°C for 2 hr, cells were stained with anti-Hsc70 antibodies. (c) Ratio of nuclear/cytoplasmic (N/C) fluorescence intensities in Hsc70. After heat shock, at least 30 transfected HuH-7 cells of control EGFP or Cx43-EGFP were examined and quantified by confocal scanning microscopy. The data shown in (b) were plotted. The horizontal lines represent mean values. * p < 0.01.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: Staining, Over Expression, Translocation Assay, Transfection, Plasmid Preparation, Fluorescence, Microscopy

(a) Effect of Cx43 on nuclear accumulation of cyclin D1. HuH-7 cells were transfected with control plasmid mRFP or Cx43-mRFP, or both Cx43-mRFP and Hsc70-DsRed2. Immunofluorescence staining with anti-cyclin D1 antibodies was carried out. Nuclear accumulation of cyclin D1 was examined and quantified by confocal laser scanning microscopy. (b) Ratio of nuclear/cytoplasmic fluorescence intensities in cyclin D1. At least 30 transfected HuH-7 cells of control mRFP or Cx43-mRFP, or both Cx43-mRFP and Hsc70-DsRed2 were examined and quantified. The data shown in (a) were plotted. The horizontal lines represent mean values. * p < 0.01.

Journal: Scientific Reports

Article Title: Connexin43 Functions as a Novel Interacting Partner of Heat Shock Cognate Protein 70

doi: 10.1038/srep02719

Figure Lengend Snippet: (a) Effect of Cx43 on nuclear accumulation of cyclin D1. HuH-7 cells were transfected with control plasmid mRFP or Cx43-mRFP, or both Cx43-mRFP and Hsc70-DsRed2. Immunofluorescence staining with anti-cyclin D1 antibodies was carried out. Nuclear accumulation of cyclin D1 was examined and quantified by confocal laser scanning microscopy. (b) Ratio of nuclear/cytoplasmic fluorescence intensities in cyclin D1. At least 30 transfected HuH-7 cells of control mRFP or Cx43-mRFP, or both Cx43-mRFP and Hsc70-DsRed2 were examined and quantified. The data shown in (a) were plotted. The horizontal lines represent mean values. * p < 0.01.

Article Snippet: The cells were then incubated with the following primary antibodies at room temperature for 2 hr: rabbit anti-Cx43 antibody (Sigma, 1:500); mouse anti-Hsc70 antibody (Santa Cruz, 1:200) or rabbit anti-Hsc70 antibody (StressMarq, Victoria, Canada, 1:250); rabbit anti-cyclin D1 antibody (Santa Cruz, 1:200); rabbit anti-p27 antibody (Santa Cruz, 1:200), and rabbit anti-Skp2 antibody (Santa Cruz, 1:200).

Techniques: Transfection, Plasmid Preparation, Immunofluorescence, Staining, Confocal Laser Scanning Microscopy, Fluorescence

Fig. 2. Signaling networks associated with the differentially expressed proteins. To identify the signal transduction pathways and/or signaling networks associated with the differentially expressed proteins, the 73 identified proteins were imported into the MINT, HPRD, and GRID databases. Yellow spots represent the target proteins with a known regulatory relationship. Red spots represent the interacting proteins. (A) Twenty-nine target proteins of the total 73 proteins were used to constructing the protein interaction network shown. (B) MAP4K1, MAP4K5, MAPK1, MAPK3, and Hsc70 (HSPA8) were present in the protein interaction network. (C) Flow chart describing the relationships between members of the MAPK pathway.

Journal: The FEBS journal

Article Title: MAPKs and Hsc70 are critical to the protective effect of molecular hydrogen during the early phase of acute pancreatitis.

doi: 10.1111/febs.13629

Figure Lengend Snippet: Fig. 2. Signaling networks associated with the differentially expressed proteins. To identify the signal transduction pathways and/or signaling networks associated with the differentially expressed proteins, the 73 identified proteins were imported into the MINT, HPRD, and GRID databases. Yellow spots represent the target proteins with a known regulatory relationship. Red spots represent the interacting proteins. (A) Twenty-nine target proteins of the total 73 proteins were used to constructing the protein interaction network shown. (B) MAP4K1, MAP4K5, MAPK1, MAPK3, and Hsc70 (HSPA8) were present in the protein interaction network. (C) Flow chart describing the relationships between members of the MAPK pathway.

Article Snippet: The section were then blocked for 30 min at room temperature and incubated overnight with monoclonal antibodies against p-ERK1/2, p-JNK1/2, p-p38 (1 : 300 dilution, Cell Signaling Technology), or Hsc70 (1 : 400 dilution, Proteintech Group) at 4 °C.

Techniques: Transduction

Fig. 6. Hydrogen upregulated Hsc70 in AP cells. (A) AR42J cells were divided into control, AP, AP+H2, and control+H2 groups. Western blot analysis demonstrated that H2 upregulated the expression of Hsc70 when the AP cells were exposed to H2. The data are expressed as means SD; *P < 0.05. (B) AR42J cells were divided into control, AP, and AP+H2 groups. The effect of H2 on the mRNA level of Hsc70 in pancreatitis cells was further analyzed by real-time PCR. The outcomes were consistent with the protein level results. The data are expressed as means SD; *P < 0.05 compared with the control group, #P < 0.05 compared with the AP group. (C) AR42J cell groups were divided into the normal cells, cells with transfection reagent and cells transfected with control siRNA or Hsc70-specific siRNA, and all four groups were exposed to cerulein and H2. Western blot analysis showed that the levels of NF-jB p65, TNF-a, and IL-1b were all significantly elevated by silencing Hsc70 expression in the AP cells using Hsc70-specific siRNA. No effect was observed in the cells transfected with the control siRNA or exposed to the transfection reagent. The data are expressed as means SD; *P < 0.05. (D) EMSA analysis confirmed that the DNA-binding activity of NF-jB p65 was significantly increased by silencing Hsc70 expression. No effect was observed in the cells transfected with the control siRNA or exposed to the transfection reagent. The data are expressed as means SD; *P < 0.05.

Journal: The FEBS journal

Article Title: MAPKs and Hsc70 are critical to the protective effect of molecular hydrogen during the early phase of acute pancreatitis.

doi: 10.1111/febs.13629

Figure Lengend Snippet: Fig. 6. Hydrogen upregulated Hsc70 in AP cells. (A) AR42J cells were divided into control, AP, AP+H2, and control+H2 groups. Western blot analysis demonstrated that H2 upregulated the expression of Hsc70 when the AP cells were exposed to H2. The data are expressed as means SD; *P < 0.05. (B) AR42J cells were divided into control, AP, and AP+H2 groups. The effect of H2 on the mRNA level of Hsc70 in pancreatitis cells was further analyzed by real-time PCR. The outcomes were consistent with the protein level results. The data are expressed as means SD; *P < 0.05 compared with the control group, #P < 0.05 compared with the AP group. (C) AR42J cell groups were divided into the normal cells, cells with transfection reagent and cells transfected with control siRNA or Hsc70-specific siRNA, and all four groups were exposed to cerulein and H2. Western blot analysis showed that the levels of NF-jB p65, TNF-a, and IL-1b were all significantly elevated by silencing Hsc70 expression in the AP cells using Hsc70-specific siRNA. No effect was observed in the cells transfected with the control siRNA or exposed to the transfection reagent. The data are expressed as means SD; *P < 0.05. (D) EMSA analysis confirmed that the DNA-binding activity of NF-jB p65 was significantly increased by silencing Hsc70 expression. No effect was observed in the cells transfected with the control siRNA or exposed to the transfection reagent. The data are expressed as means SD; *P < 0.05.

Article Snippet: The section were then blocked for 30 min at room temperature and incubated overnight with monoclonal antibodies against p-ERK1/2, p-JNK1/2, p-p38 (1 : 300 dilution, Cell Signaling Technology), or Hsc70 (1 : 400 dilution, Proteintech Group) at 4 °C.

Techniques: Control, Western Blot, Expressing, Real-time Polymerase Chain Reaction, Transfection, Binding Assay, Activity Assay

Fig. 7. Verification experiments in vivo. (A) All animals were randomly allocated into three experimental groups: the sham group was provided normal room air through an anesthetic gas vaporizer utilizing a facial mask after the sham operation; the AP group received the same treatment after inducing AP with a retrograde infusion of 3.5% sodium taurocholate into the pancreatobiliary duct; and the AP+H2 group was administered 2% hydrogen gas supplemented with 98% balanced air through an anesthetic gas vaporizer utilizing a facial mask after inducing AP. All animals were sacrificed 24 h after inducing AP. Western blot analysis verified the outcomes of the in vitro experiments in terms of the p-ERK, p-JNK, p-p38, and Hsc70 levels associated with H2 treatment. H2 inhalation inhibited the activation of the MAPK pathways and increased the protein level of Hsc70. The data are expressed as means SD; *P < 0.05. (B) Histological examination was performed to evaluate the therapeutic effect of H2 in vivo. Immunohistological staining confirmed the results of the previous experiments. The expression of p-ERK, p-JNK, and p-p38 in pancreatic acinar cells was significantly decreased and the Hsc70 protein level was significantly increased after H2 exposure. The scale bar represents 50 lm. (C) Animals were randomly allocated into four experimental groups: the AP+H2 group was treated as described above, and the AP+H2 + PD98059, SP600125 or SB203580 group received an intraperitoneal injection of 1 mL of the corresponding specific inhibitor solution (15 mgkg1) at 30 min before the surgical procedure. All animals were sacrificed 24 h after AP induction. The levels of p-ERK1/2, p-JNK1/2, and p-p38 were all elevated in the AP+H2 group compared with the MAPK-inhibition groups. Combined treatment with H2 and the corresponding specific inhibitor significantly attenuated the increased expression of these proteins. Simultaneously, the levels of these indexes in the other two groups were between those observed in the AP+H2 group, and the AP+H2 + the corresponding specific inhibitor group. The data are expressed as means SD; *P < 0.05.

Journal: The FEBS journal

Article Title: MAPKs and Hsc70 are critical to the protective effect of molecular hydrogen during the early phase of acute pancreatitis.

doi: 10.1111/febs.13629

Figure Lengend Snippet: Fig. 7. Verification experiments in vivo. (A) All animals were randomly allocated into three experimental groups: the sham group was provided normal room air through an anesthetic gas vaporizer utilizing a facial mask after the sham operation; the AP group received the same treatment after inducing AP with a retrograde infusion of 3.5% sodium taurocholate into the pancreatobiliary duct; and the AP+H2 group was administered 2% hydrogen gas supplemented with 98% balanced air through an anesthetic gas vaporizer utilizing a facial mask after inducing AP. All animals were sacrificed 24 h after inducing AP. Western blot analysis verified the outcomes of the in vitro experiments in terms of the p-ERK, p-JNK, p-p38, and Hsc70 levels associated with H2 treatment. H2 inhalation inhibited the activation of the MAPK pathways and increased the protein level of Hsc70. The data are expressed as means SD; *P < 0.05. (B) Histological examination was performed to evaluate the therapeutic effect of H2 in vivo. Immunohistological staining confirmed the results of the previous experiments. The expression of p-ERK, p-JNK, and p-p38 in pancreatic acinar cells was significantly decreased and the Hsc70 protein level was significantly increased after H2 exposure. The scale bar represents 50 lm. (C) Animals were randomly allocated into four experimental groups: the AP+H2 group was treated as described above, and the AP+H2 + PD98059, SP600125 or SB203580 group received an intraperitoneal injection of 1 mL of the corresponding specific inhibitor solution (15 mgkg1) at 30 min before the surgical procedure. All animals were sacrificed 24 h after AP induction. The levels of p-ERK1/2, p-JNK1/2, and p-p38 were all elevated in the AP+H2 group compared with the MAPK-inhibition groups. Combined treatment with H2 and the corresponding specific inhibitor significantly attenuated the increased expression of these proteins. Simultaneously, the levels of these indexes in the other two groups were between those observed in the AP+H2 group, and the AP+H2 + the corresponding specific inhibitor group. The data are expressed as means SD; *P < 0.05.

Article Snippet: The section were then blocked for 30 min at room temperature and incubated overnight with monoclonal antibodies against p-ERK1/2, p-JNK1/2, p-p38 (1 : 300 dilution, Cell Signaling Technology), or Hsc70 (1 : 400 dilution, Proteintech Group) at 4 °C.

Techniques: In Vivo, Western Blot, In Vitro, Activation Assay, Staining, Expressing, Injection, Inhibition

(A–C) Degradation assay in immunofluorescence against Ca V 1.2 (A) and Ca V 2.3 (B) of primary beta cells of the indicated genotypes after the CHX treatment of the indicated periods; accompanied by their quantification along with that of α-tubulin (C). Bars, 5 μm. * p < 0.05, *** p < 0.001, Welch’s t test at the indicated time; n = 6 (Ca V 1.2), 17–24 (Ca V 2.3), 5–6 (α-tubulin). (D and E) Brefeldin-A (BFA) washout assay with an LSM 5LIVE-Duo microscope, assessing the speeds of post-Golgi trafficking of Ca V 1.2-EGFP proteins expressed in primary beta cells of the indicated genotypes (D), accompanied by its quantification (E). Time after BFA washout is indicated. Bar, 5 μm. *p < 0.05, Welch’s t test, n = 11. Arrows, the timing of plasma membrane fusion. Corresponding to Movie EV4. (F) TIRF/STORM microscopy of a wild-type primary mouse beta cell immunolabeled against Ca V 1.2 and KIF5B. Scale bar, 5 μm. Arrows, colocalizing spots. (G) TIRF/STORM microscopy of primary mouse beta cells of the indicated genotypes immunolabeled against Ca V 1.2 (green) and Ca V 2.3 (magenta). Scale bars, 5 μm. (H) Schematic representation of STIP1-dependent Hsp70-to-Hsp90 chaperone exchange machinery. (I and J) z -projection of proximity ligation assay in CT and cKO primary beta cells showing the protein binding between Ca V 1.2 and the indicated Hsp proteins (I); accompanied by quantification (J). ** p < 0.01; *** p < 0.001; Welch’s t test, n = 6. (K) Immunoblotting of scramble control (SC) and STIP1-knockdown (KD) MIN6 cells against the indicated epitopes. Note that STIP1 deficiency induced downregulation of Ca V 1.2 and BK Ca proteins. Reproduced twice.

Journal: bioRxiv

Article Title: Kinesin-1 mediates proper ER folding of the Ca V 1.2 channel and maintains mouse glucose homeostasis

doi: 10.1101/2024.06.24.600327

Figure Lengend Snippet: (A–C) Degradation assay in immunofluorescence against Ca V 1.2 (A) and Ca V 2.3 (B) of primary beta cells of the indicated genotypes after the CHX treatment of the indicated periods; accompanied by their quantification along with that of α-tubulin (C). Bars, 5 μm. * p < 0.05, *** p < 0.001, Welch’s t test at the indicated time; n = 6 (Ca V 1.2), 17–24 (Ca V 2.3), 5–6 (α-tubulin). (D and E) Brefeldin-A (BFA) washout assay with an LSM 5LIVE-Duo microscope, assessing the speeds of post-Golgi trafficking of Ca V 1.2-EGFP proteins expressed in primary beta cells of the indicated genotypes (D), accompanied by its quantification (E). Time after BFA washout is indicated. Bar, 5 μm. *p < 0.05, Welch’s t test, n = 11. Arrows, the timing of plasma membrane fusion. Corresponding to Movie EV4. (F) TIRF/STORM microscopy of a wild-type primary mouse beta cell immunolabeled against Ca V 1.2 and KIF5B. Scale bar, 5 μm. Arrows, colocalizing spots. (G) TIRF/STORM microscopy of primary mouse beta cells of the indicated genotypes immunolabeled against Ca V 1.2 (green) and Ca V 2.3 (magenta). Scale bars, 5 μm. (H) Schematic representation of STIP1-dependent Hsp70-to-Hsp90 chaperone exchange machinery. (I and J) z -projection of proximity ligation assay in CT and cKO primary beta cells showing the protein binding between Ca V 1.2 and the indicated Hsp proteins (I); accompanied by quantification (J). ** p < 0.01; *** p < 0.001; Welch’s t test, n = 6. (K) Immunoblotting of scramble control (SC) and STIP1-knockdown (KD) MIN6 cells against the indicated epitopes. Note that STIP1 deficiency induced downregulation of Ca V 1.2 and BK Ca proteins. Reproduced twice.

Article Snippet: A rabbit anti-Ca V 1.2 antibody (N-17-R, #sc-16229-R, RRID:AB_2228387), a rabbit anti-K ir 6.2 antibody (H-55; #sc-20809; RRID:AB_2130466), a goat anti-PIP5Kα (PIPKIα) antibody (M-20, #sc-11775; RRID:AB_2268303), and a goat anti-SUR1 antibody (N-18, #sc-11226; RRID:AB_2130475) were purchased from Santa Cruz Biotechnology; a mouse anti-PIP 2 IgM antibody (#Z-A045, RRID:AB_427211) was from Echelon Research labs; a rabbit anti-GFP antibody (#598, RRID:AB_591819) was from MBL; a mouse anti-LC3 antibody (Clone LC3-1703, #CTB-LC3-2-IC, RRID:AB_10707197) was from Cosmo Bio; a rabbit anti-BK Ca (K Ca 1.1) antibody (#APC-151, RRID:AB_10915895) and a rabbit anti-Ca V 2.3 antibody (#ACC-006, RRID:AB_2039777) were from Alomone Labs; a mouse anti-syntaxin-1 antibody (#MAB336, RRID:AB_2196527) was from Millipore; a mouse anti-Na/K ATPase beta 2 antibody (#610914; RRID:AB_398231) and a mouse anti-paxillin antibody (#610051, RRID:AB_397463) were from BD Transduction Labs; a mouse anti-Hsc70/Hsp70 antibody (Clone BB70, #ADI-SPA-822-D, RRID:AB_2039252) and a rat anti-Hsp90 antibody (Clone 16F1, #ADI-SPA-835-D, RRID:AB_2039281) were from Enzo; a rabbit anti-STIP1 antibody (#15218-1-AP; RRID:AB_2255518) and a rabbit anti-calnexin-1 (CANX) antibody (#10427-2-AP, RRID:AB_2069033) were from Proteintech; a mouse anti-derlin-1 antibody (#SAB4200148, RRID:AB_10624068), an anti-α-tubulin antibody (Clone DM1A; #CP06; RRID:AB_2617116), and an anti-insulin antibody (Clone K36aC10, #I-2018, Sigma Aldrich; RRID:AB_260137) were from Sigma Aldrich; a rabbit anti-phospho Src antibody for pSFK (#ab32078; RRID:AB_2286707) was from Epitomics/Abcam; and a rabbit anti-KIF5B antibody (RRID:AB_2571745) was previously described ( Tanaka et al ., 1998 ).

Techniques: Degradation Assay, Immunofluorescence, Microscopy, Clinical Proteomics, Membrane, Immunolabeling, Proximity Ligation Assay, Protein Binding, Western Blot, Control, Knockdown

(A and B) Rescue of Ca V 1.2 degradation in cKO primary beta cells in the presence of CHX by leupeptin (Leu) or MG-132 (MG) for 4 h. ns, p > 0.05; * p < 0.05; one-way ANOVA, n = 12. (C and D) Vesicle IP of MG-132-treated MIN6 cell lysates transduced with scrambled control (SC) and KIF5B-knockdown (KD) miRNAs, precipitated using Ca V 1.2 or K ir 6.2 antibodies or normal rabbit IgG (NRG) and immunoblotted for the indicated proteins (C), accompanied by quantification of Ca V 1.2-coprecipitated fractions (D). Note that the Ca V 1.2-binding capacities of derlin-1, calnexin-1, and Hsp90 chaperones and that of the adaptor protein STIP1 in KD cell lysates were significantly lower than those in SC cell lysates. (E) Vesicle IP of the MG-132-treated MIN6 cell lysates among the KIF5B KD system against STIP1. Note that the Hsp90 level in the STIP1 immunoprecipitants (IP) was greatly decreased by KIF5B deficiency. Repeated twice. (F) Schematic representation of the working hypothesis on differential KIF5B- and heat-shock-protein (Hsp)-dependencies of opposing ER clients Ca V 1.2 and K ir 6.2 in control (CT) and KIF5B conditional knockout (cKO) mouse beta cells. In cKO cells, Ca V 1.2 fails in chaperone exchange to undergo ERAD-mediated degradation, but K ir 6.2 is intact because it is independent on the KIF5B–Hsp machinery. (G and H) Ca V 1.2 immunocytochemistry of MIN6 cells that had been transduced with EYFP-KIF5B and/or TagRFP-Hsc70 or without them (NT; G); accompanied by their quantification (H). Scale bar, 5 μm. ns, p > 0.05; ** p < 0.01, one-way ANOVA, n = 5–13. Arrow in G, enhanced Ca V 1.2 expression according to dual overexpression. (I) Vesicle IP of non-transduced (NT) and KIF5B- and Hsc70-overexpressing (K5+H70 OE) MIN6 cell lysates against Ca V 1.2. Asterisks, tagged protein bands. The tagRFP-Hsc70 band was overlapped with a band of possibly ubiquitinated form. Reproduced twice.

Journal: bioRxiv

Article Title: Kinesin-1 mediates proper ER folding of the Ca V 1.2 channel and maintains mouse glucose homeostasis

doi: 10.1101/2024.06.24.600327

Figure Lengend Snippet: (A and B) Rescue of Ca V 1.2 degradation in cKO primary beta cells in the presence of CHX by leupeptin (Leu) or MG-132 (MG) for 4 h. ns, p > 0.05; * p < 0.05; one-way ANOVA, n = 12. (C and D) Vesicle IP of MG-132-treated MIN6 cell lysates transduced with scrambled control (SC) and KIF5B-knockdown (KD) miRNAs, precipitated using Ca V 1.2 or K ir 6.2 antibodies or normal rabbit IgG (NRG) and immunoblotted for the indicated proteins (C), accompanied by quantification of Ca V 1.2-coprecipitated fractions (D). Note that the Ca V 1.2-binding capacities of derlin-1, calnexin-1, and Hsp90 chaperones and that of the adaptor protein STIP1 in KD cell lysates were significantly lower than those in SC cell lysates. (E) Vesicle IP of the MG-132-treated MIN6 cell lysates among the KIF5B KD system against STIP1. Note that the Hsp90 level in the STIP1 immunoprecipitants (IP) was greatly decreased by KIF5B deficiency. Repeated twice. (F) Schematic representation of the working hypothesis on differential KIF5B- and heat-shock-protein (Hsp)-dependencies of opposing ER clients Ca V 1.2 and K ir 6.2 in control (CT) and KIF5B conditional knockout (cKO) mouse beta cells. In cKO cells, Ca V 1.2 fails in chaperone exchange to undergo ERAD-mediated degradation, but K ir 6.2 is intact because it is independent on the KIF5B–Hsp machinery. (G and H) Ca V 1.2 immunocytochemistry of MIN6 cells that had been transduced with EYFP-KIF5B and/or TagRFP-Hsc70 or without them (NT; G); accompanied by their quantification (H). Scale bar, 5 μm. ns, p > 0.05; ** p < 0.01, one-way ANOVA, n = 5–13. Arrow in G, enhanced Ca V 1.2 expression according to dual overexpression. (I) Vesicle IP of non-transduced (NT) and KIF5B- and Hsc70-overexpressing (K5+H70 OE) MIN6 cell lysates against Ca V 1.2. Asterisks, tagged protein bands. The tagRFP-Hsc70 band was overlapped with a band of possibly ubiquitinated form. Reproduced twice.

Article Snippet: A rabbit anti-Ca V 1.2 antibody (N-17-R, #sc-16229-R, RRID:AB_2228387), a rabbit anti-K ir 6.2 antibody (H-55; #sc-20809; RRID:AB_2130466), a goat anti-PIP5Kα (PIPKIα) antibody (M-20, #sc-11775; RRID:AB_2268303), and a goat anti-SUR1 antibody (N-18, #sc-11226; RRID:AB_2130475) were purchased from Santa Cruz Biotechnology; a mouse anti-PIP 2 IgM antibody (#Z-A045, RRID:AB_427211) was from Echelon Research labs; a rabbit anti-GFP antibody (#598, RRID:AB_591819) was from MBL; a mouse anti-LC3 antibody (Clone LC3-1703, #CTB-LC3-2-IC, RRID:AB_10707197) was from Cosmo Bio; a rabbit anti-BK Ca (K Ca 1.1) antibody (#APC-151, RRID:AB_10915895) and a rabbit anti-Ca V 2.3 antibody (#ACC-006, RRID:AB_2039777) were from Alomone Labs; a mouse anti-syntaxin-1 antibody (#MAB336, RRID:AB_2196527) was from Millipore; a mouse anti-Na/K ATPase beta 2 antibody (#610914; RRID:AB_398231) and a mouse anti-paxillin antibody (#610051, RRID:AB_397463) were from BD Transduction Labs; a mouse anti-Hsc70/Hsp70 antibody (Clone BB70, #ADI-SPA-822-D, RRID:AB_2039252) and a rat anti-Hsp90 antibody (Clone 16F1, #ADI-SPA-835-D, RRID:AB_2039281) were from Enzo; a rabbit anti-STIP1 antibody (#15218-1-AP; RRID:AB_2255518) and a rabbit anti-calnexin-1 (CANX) antibody (#10427-2-AP, RRID:AB_2069033) were from Proteintech; a mouse anti-derlin-1 antibody (#SAB4200148, RRID:AB_10624068), an anti-α-tubulin antibody (Clone DM1A; #CP06; RRID:AB_2617116), and an anti-insulin antibody (Clone K36aC10, #I-2018, Sigma Aldrich; RRID:AB_260137) were from Sigma Aldrich; a rabbit anti-phospho Src antibody for pSFK (#ab32078; RRID:AB_2286707) was from Epitomics/Abcam; and a rabbit anti-KIF5B antibody (RRID:AB_2571745) was previously described ( Tanaka et al ., 1998 ).

Techniques: Transduction, Control, Knockdown, Binding Assay, Knock-Out, Immunocytochemistry, Expressing, Over Expression

HSPA8 is a target of LACTB. A. qRT-PCR testing the effects of LACTB overexpression and knockout on HSPA8 mRNA levels. B. Western blot testing the indicated protein levels after LACTB overexpression in SK-HEP-1 cells. C. Western blot testing the indicated protein levels in LACTB −/− cells reexpressing LACTB. D. Western blot testing the indicated protein levels in LACTB-expressing cells transfected with HSPA8-expressing plasmid. E. Western blot testing the indicated protein levels in LACTB −/− cells transfected with si-HSPA8. F–I. Detection of effects of LACTB overexpression or in combination with HSPA8 overexpression on Fe 2+ , lipid peroxidation, MDA levels and GSH/GSSG ratio in cells. Scale bar = 25 μm. J,K. Detection of effects of LACTB knockout or in combination with HSPA8 silencing on Fe 2+ and lipid peroxidation levels in HepG2 and SK-HEP-1 cells. Scale bar = 25 μm. L. Kaplan-Meier plotter database showing the overall survival rate of liver cancer patients with high or low HSPA8 expression. M. Xenograft tumour model testing the in vivo effects of LACTB or LACTB + HSPA8 on SK-HEP-1 cell growth. Scale bar = 1 cm. Student's t -test was used for A (left panel), one-way ANOVA with Tukey post-hoc test was used for A (right panel), F–K, M (right panel), and two-way ANOVA with Tukey post-hoc test was used for M (middle panel).

Journal: Redox Biology

Article Title: LACTB suppresses liver cancer progression through regulation of ferroptosis

doi: 10.1016/j.redox.2024.103270

Figure Lengend Snippet: HSPA8 is a target of LACTB. A. qRT-PCR testing the effects of LACTB overexpression and knockout on HSPA8 mRNA levels. B. Western blot testing the indicated protein levels after LACTB overexpression in SK-HEP-1 cells. C. Western blot testing the indicated protein levels in LACTB −/− cells reexpressing LACTB. D. Western blot testing the indicated protein levels in LACTB-expressing cells transfected with HSPA8-expressing plasmid. E. Western blot testing the indicated protein levels in LACTB −/− cells transfected with si-HSPA8. F–I. Detection of effects of LACTB overexpression or in combination with HSPA8 overexpression on Fe 2+ , lipid peroxidation, MDA levels and GSH/GSSG ratio in cells. Scale bar = 25 μm. J,K. Detection of effects of LACTB knockout or in combination with HSPA8 silencing on Fe 2+ and lipid peroxidation levels in HepG2 and SK-HEP-1 cells. Scale bar = 25 μm. L. Kaplan-Meier plotter database showing the overall survival rate of liver cancer patients with high or low HSPA8 expression. M. Xenograft tumour model testing the in vivo effects of LACTB or LACTB + HSPA8 on SK-HEP-1 cell growth. Scale bar = 1 cm. Student's t -test was used for A (left panel), one-way ANOVA with Tukey post-hoc test was used for A (right panel), F–K, M (right panel), and two-way ANOVA with Tukey post-hoc test was used for M (middle panel).

Article Snippet: The sections were then incubated with anti -LACTB (#18195-1-AP, Proteintech), anti -p53 (wild-type) (#MABE339, Sigma-Aldrich), and anti -HSPA8 (#M01024-1, BOSTER) primary antibodies and a DAKO peroxidase-labelled secondary antibody.

Techniques: Quantitative RT-PCR, Over Expression, Knock-Out, Western Blot, Expressing, Transfection, Plasmid Preparation, In Vivo

LACTB drives ferroptosis via regulating the p53/HSPA8 axis. A. qRT-PCR testing HSPA8 mRNA levels in LACTB-expressing Huh7 and Hep3B cells. B, C. qRT-PCR and Western blot testing HSPA8 mRNA and protein levels in LACTB-expressing cells transfected with si-p53. D. Western blot testing p53 protein expression in LACTB-expressing SK-HEP-1 cells treated with 100 μg/mL cycloheximide for the indicated time. E. Western blot testing p53 ubiquitination levels in LACTB-expressing SK-HEP-1 cells. F. Western blot testing HSPA8 protein expression in LACTB-expressing p53 +/+ Hep3B cells. G. Luciferase reporter assay testing HSPA8 promoter activity in LACTB-expressing cells transfected with si-p53. H. p53 binding sites on HSPA8 promoter among different species. I. The schema showing the wild-type or mutant p53 binding motifs on HSPA8 or p21 promoter, and primer design positions for ChIP assay. J. ChIP assay testing the binding of p53 on the indicated regions of HSPA8 promoter. K. DNA pull-down assay using wild-type or mutant HSPA8 promoter probe, followed by Western blot analysis of p53 protein expression. L. Generation of SK-HEP-1 cells with endogenous mutation of p53 binding site in HSPA8 promoter using CRISPR/Cas9 gene editing technology with the indicated ssODN and gRNA. M. CCK-8 testing the viability of wild-type or mutant SK-HEP-1 cells treated with erastin and RSL3. N, O. Liperfluo and FerroOrange staining testing lipid peroxidation and Fe 2+ levels in wild-type or mutant SK-HEP-1 cells. Scale bar = 25 μm. P. Western blot testing HSPA8 protein levels in wild-type or mutant SK-HEP-1 cells with LACTB or p53 overexpression. Q. IHC staining of LACTB, wild-type (wt) p53 and HSPA8 in liver cancer tissue microarray, followed by analysis of their expression correlations. Scale bar = 50 μm. One-way ANOVA with Tukey post-hoc test was used for B and G. Student's t -test was used for J, N, O.

Journal: Redox Biology

Article Title: LACTB suppresses liver cancer progression through regulation of ferroptosis

doi: 10.1016/j.redox.2024.103270

Figure Lengend Snippet: LACTB drives ferroptosis via regulating the p53/HSPA8 axis. A. qRT-PCR testing HSPA8 mRNA levels in LACTB-expressing Huh7 and Hep3B cells. B, C. qRT-PCR and Western blot testing HSPA8 mRNA and protein levels in LACTB-expressing cells transfected with si-p53. D. Western blot testing p53 protein expression in LACTB-expressing SK-HEP-1 cells treated with 100 μg/mL cycloheximide for the indicated time. E. Western blot testing p53 ubiquitination levels in LACTB-expressing SK-HEP-1 cells. F. Western blot testing HSPA8 protein expression in LACTB-expressing p53 +/+ Hep3B cells. G. Luciferase reporter assay testing HSPA8 promoter activity in LACTB-expressing cells transfected with si-p53. H. p53 binding sites on HSPA8 promoter among different species. I. The schema showing the wild-type or mutant p53 binding motifs on HSPA8 or p21 promoter, and primer design positions for ChIP assay. J. ChIP assay testing the binding of p53 on the indicated regions of HSPA8 promoter. K. DNA pull-down assay using wild-type or mutant HSPA8 promoter probe, followed by Western blot analysis of p53 protein expression. L. Generation of SK-HEP-1 cells with endogenous mutation of p53 binding site in HSPA8 promoter using CRISPR/Cas9 gene editing technology with the indicated ssODN and gRNA. M. CCK-8 testing the viability of wild-type or mutant SK-HEP-1 cells treated with erastin and RSL3. N, O. Liperfluo and FerroOrange staining testing lipid peroxidation and Fe 2+ levels in wild-type or mutant SK-HEP-1 cells. Scale bar = 25 μm. P. Western blot testing HSPA8 protein levels in wild-type or mutant SK-HEP-1 cells with LACTB or p53 overexpression. Q. IHC staining of LACTB, wild-type (wt) p53 and HSPA8 in liver cancer tissue microarray, followed by analysis of their expression correlations. Scale bar = 50 μm. One-way ANOVA with Tukey post-hoc test was used for B and G. Student's t -test was used for J, N, O.

Article Snippet: The sections were then incubated with anti -LACTB (#18195-1-AP, Proteintech), anti -p53 (wild-type) (#MABE339, Sigma-Aldrich), and anti -HSPA8 (#M01024-1, BOSTER) primary antibodies and a DAKO peroxidase-labelled secondary antibody.

Techniques: Quantitative RT-PCR, Expressing, Western Blot, Transfection, Ubiquitin Proteomics, Luciferase, Reporter Assay, Activity Assay, Binding Assay, Mutagenesis, Pull Down Assay, CRISPR, CCK-8 Assay, Staining, Over Expression, Immunohistochemistry, Microarray

LACTB potentiates the response of liver cancer to lenvatinib. A, B. FerroOrange and liperfluo staining testing Fe 2+ and lipid peroxidation levels in HepG2 and SK-HEP-1 cells treated with lenvatinib, respectively. Scale bar = 25 μm. C. Western blot testing LACTB protein expression in HepG2 and SK-HEP-1 cells treated with lenvatinib. D-G. FerroOrange, liperfluo staining, CCK-8 and colony formation assays respectively testing Fe 2+ , lipid peroxidation levels, viability and cloning ability in lenvatinib-treated cells with LACTB overexpression or knockout. H, I. Xenograft tumour model testing the in vivo effects of LACTB overexpression or knockout on the anti-tumour effect of lenvatinib. Scale bar = 1 cm. J. Western blot testing the indicated protein expression in the indicated groups. K. The proposed model showing that LACTB induced by lenvatinib promotes ferroptosis by increasing p53 protein stability and inhibiting HSPA8-mediated anti -ferroptosis pathway. One-way ANOVA with Tukey post-hoc test was used for A, B, D-G, I.

Journal: Redox Biology

Article Title: LACTB suppresses liver cancer progression through regulation of ferroptosis

doi: 10.1016/j.redox.2024.103270

Figure Lengend Snippet: LACTB potentiates the response of liver cancer to lenvatinib. A, B. FerroOrange and liperfluo staining testing Fe 2+ and lipid peroxidation levels in HepG2 and SK-HEP-1 cells treated with lenvatinib, respectively. Scale bar = 25 μm. C. Western blot testing LACTB protein expression in HepG2 and SK-HEP-1 cells treated with lenvatinib. D-G. FerroOrange, liperfluo staining, CCK-8 and colony formation assays respectively testing Fe 2+ , lipid peroxidation levels, viability and cloning ability in lenvatinib-treated cells with LACTB overexpression or knockout. H, I. Xenograft tumour model testing the in vivo effects of LACTB overexpression or knockout on the anti-tumour effect of lenvatinib. Scale bar = 1 cm. J. Western blot testing the indicated protein expression in the indicated groups. K. The proposed model showing that LACTB induced by lenvatinib promotes ferroptosis by increasing p53 protein stability and inhibiting HSPA8-mediated anti -ferroptosis pathway. One-way ANOVA with Tukey post-hoc test was used for A, B, D-G, I.

Article Snippet: The sections were then incubated with anti -LACTB (#18195-1-AP, Proteintech), anti -p53 (wild-type) (#MABE339, Sigma-Aldrich), and anti -HSPA8 (#M01024-1, BOSTER) primary antibodies and a DAKO peroxidase-labelled secondary antibody.

Techniques: Staining, Western Blot, Expressing, CCK-8 Assay, Cloning, Over Expression, Knock-Out, In Vivo

Co-immunoprecipitation (co-IP) of ChAT with heat shock proteins HSC70, HSP70, and HSP90 is altered by mutation of N-terminal proline-rich motif in ChAT. (A) Immunoblots showing co-IP of ChAT with endogenous HSC70, HSP70 and HSP90 from HEK293 cells expressing either wild-type or P17A/P19A-ChAT. Control cells were transfected with empty vector. Using HEK293 cells, co-IP of P17A/P19A-ChAT with HSP70 (B) , HSP90 (C) and HSC70 (D) , respectively, is greater than that of wild-type ChAT ( *** p ≤ 0.001, Student's t -test, mean ± SEM, n = 4). (E) Co-IP of ChAT with endogenous HSC70 and HSP90 from mouse cholinergic SN56 cells expressing either wild-type or P17A/P19A-ChAT or CMS-related mutant proteins V18M- or A513T-ChAT. Control cells were transfected with empty vector. (F) Using SN56 cells, Co-IP of P17A/P19A-ChAT ( *** p ≤ 0.001) and V18M-ChAT ( * p ≤ 0.05), but not A531T-ChAT, with HSC70 is greater than that of wild-type ChAT (mean ± SEM, n = 5). (G) While there was a trend toward increased HSP90 interaction with P17A/P19A-ChAT ( p = 0.09), no significant differences were observed for HSP90 interaction with mutant ChAT compared to wild-type ChAT in SN56 cells (mean ± SEM, n = 5). Statistical analysis for (F) and (G) was performed by one-way ANOVA with Dunnett's post-hoc test. (H) Detection of in situ interactions of wild-type ChAT with endogenous HSC70 and HSP90 by proximity ligation assay (PLA) in SN56 cells. Formalin-fixed cells were first co-labeled with goat anti-ChAT together with either mouse anti-HSC70 or mouse anti-HSP90 primary antibodies, then incubated with oligonucleotide-linked secondary antibodies. Following DNA ligation and DNA amplification using the Duolink in Situ Orange Kit (Sigma), in situ ChAT-HSP interactions were imaged by confocal microscopy. Positive in situ ChAT-HSP interactions where visualized as fluorescent red dots while nuclei were stained with DAPI (blue). Control cells were either transfected with empty vector or had primary antibodies omitted from the assay (No 1° antibodies). Images are representative of 3 independent experiments; scale bars are 10 μm.

Journal: Frontiers in Molecular Neuroscience

Article Title: Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP

doi: 10.3389/fnmol.2017.00415

Figure Lengend Snippet: Co-immunoprecipitation (co-IP) of ChAT with heat shock proteins HSC70, HSP70, and HSP90 is altered by mutation of N-terminal proline-rich motif in ChAT. (A) Immunoblots showing co-IP of ChAT with endogenous HSC70, HSP70 and HSP90 from HEK293 cells expressing either wild-type or P17A/P19A-ChAT. Control cells were transfected with empty vector. Using HEK293 cells, co-IP of P17A/P19A-ChAT with HSP70 (B) , HSP90 (C) and HSC70 (D) , respectively, is greater than that of wild-type ChAT ( *** p ≤ 0.001, Student's t -test, mean ± SEM, n = 4). (E) Co-IP of ChAT with endogenous HSC70 and HSP90 from mouse cholinergic SN56 cells expressing either wild-type or P17A/P19A-ChAT or CMS-related mutant proteins V18M- or A513T-ChAT. Control cells were transfected with empty vector. (F) Using SN56 cells, Co-IP of P17A/P19A-ChAT ( *** p ≤ 0.001) and V18M-ChAT ( * p ≤ 0.05), but not A531T-ChAT, with HSC70 is greater than that of wild-type ChAT (mean ± SEM, n = 5). (G) While there was a trend toward increased HSP90 interaction with P17A/P19A-ChAT ( p = 0.09), no significant differences were observed for HSP90 interaction with mutant ChAT compared to wild-type ChAT in SN56 cells (mean ± SEM, n = 5). Statistical analysis for (F) and (G) was performed by one-way ANOVA with Dunnett's post-hoc test. (H) Detection of in situ interactions of wild-type ChAT with endogenous HSC70 and HSP90 by proximity ligation assay (PLA) in SN56 cells. Formalin-fixed cells were first co-labeled with goat anti-ChAT together with either mouse anti-HSC70 or mouse anti-HSP90 primary antibodies, then incubated with oligonucleotide-linked secondary antibodies. Following DNA ligation and DNA amplification using the Duolink in Situ Orange Kit (Sigma), in situ ChAT-HSP interactions were imaged by confocal microscopy. Positive in situ ChAT-HSP interactions where visualized as fluorescent red dots while nuclei were stained with DAPI (blue). Control cells were either transfected with empty vector or had primary antibodies omitted from the assay (No 1° antibodies). Images are representative of 3 independent experiments; scale bars are 10 μm.

Article Snippet: Cells were washed with HBSS, formalin-fixed (4% paraformaldehyde in HBSS) for 15 min, permeabilized with 0.1% Triton X-100, blocked for 1 h in HBSS supplemented with 3% donkey serum, then finally incubated for 1 h with primary antibodies targeting ChAT (1:100; Chemicon, goat primary) together with either endogenous HSC70 (1:100; StressMarq, mouse primary), HSP90 (1:200; StressMarq, mouse primary) or CHIP (1:200; Santa Cruz, rabbit primary); all steps were performed at room temperature.

Techniques: Immunoprecipitation, Co-Immunoprecipitation Assay, Mutagenesis, Western Blot, Expressing, Transfection, Plasmid Preparation, In Situ, Proximity Ligation Assay, Labeling, Incubation, DNA Ligation, Amplification, Confocal Microscopy, Staining

ChAT interacts with the HSP-associated E3 ubiquitin ligase C-terminus of HSC70-interaction protein (CHIP). (A) Immunoblots showing co-IP of ChAT with FLAG-CHIP from SN56 cells co-expressing either wild-type or mutant ChAT protein with FLAG-tagged CHIP. Control cells were transfected with either empty vector or to express either wild-type ChAT or FLAG-CHIP alone. (B) Co-IP of ChAT with FLAG-CHIP is enhanced for P17A/P19A- ( *** p ≤ 0.001), V18M- ( *** p ≤ 0.001), and A513T-ChAT ( * p ≤ 0.05) as compared to wild-type ChAT (one-way ANOVA with Dunnett's post-hoc test, mean ± SEM, n = 5). (C) Co-IP of wild-type and mutant ChAT with endogenous CHIP following anti-ChAT co-IP from ChAT-expressing SN56 cells ( n = 3). (D) Detection of in situ ChAT interactions with endogenous CHIP by proximity ligation assay (PLA) in SN56 cells expressing wild-type ChAT. Formalin-fixed cells were first co-labeled with goat anti-ChAT together with rabbit anti-CHIP primary antibodies, then incubated with oligonucleotide-linked secondary antibodies. Following DNA ligation and DNA amplification using the Duolink In Situ Orange Kit (Sigma), in situ ChAT-CHIP interactions were imaged by confocal microscopy. Positive in situ ChAT-CHIP interactions were visualized as fluorescent red dots while nuclei were stained with DAPI (blue). Control cells were either transfected with empty vector or primary antibodies omitted from the assay (No 1° antibodies). Images are representative of 4 independent experiments; scale bars are 10 μm. (E) siRNA-mediated knock-down of CHIP has no effect on the steady-state protein levels of either wild-type or mutant ChAT. ChAT-expressing SN56 cells were co-transfected with 25 nM of either anti-CHIP siRNA or scramble-control siRNA for 72 h. Control cells were mock-transfected ( n = 4).

Journal: Frontiers in Molecular Neuroscience

Article Title: Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP

doi: 10.3389/fnmol.2017.00415

Figure Lengend Snippet: ChAT interacts with the HSP-associated E3 ubiquitin ligase C-terminus of HSC70-interaction protein (CHIP). (A) Immunoblots showing co-IP of ChAT with FLAG-CHIP from SN56 cells co-expressing either wild-type or mutant ChAT protein with FLAG-tagged CHIP. Control cells were transfected with either empty vector or to express either wild-type ChAT or FLAG-CHIP alone. (B) Co-IP of ChAT with FLAG-CHIP is enhanced for P17A/P19A- ( *** p ≤ 0.001), V18M- ( *** p ≤ 0.001), and A513T-ChAT ( * p ≤ 0.05) as compared to wild-type ChAT (one-way ANOVA with Dunnett's post-hoc test, mean ± SEM, n = 5). (C) Co-IP of wild-type and mutant ChAT with endogenous CHIP following anti-ChAT co-IP from ChAT-expressing SN56 cells ( n = 3). (D) Detection of in situ ChAT interactions with endogenous CHIP by proximity ligation assay (PLA) in SN56 cells expressing wild-type ChAT. Formalin-fixed cells were first co-labeled with goat anti-ChAT together with rabbit anti-CHIP primary antibodies, then incubated with oligonucleotide-linked secondary antibodies. Following DNA ligation and DNA amplification using the Duolink In Situ Orange Kit (Sigma), in situ ChAT-CHIP interactions were imaged by confocal microscopy. Positive in situ ChAT-CHIP interactions were visualized as fluorescent red dots while nuclei were stained with DAPI (blue). Control cells were either transfected with empty vector or primary antibodies omitted from the assay (No 1° antibodies). Images are representative of 4 independent experiments; scale bars are 10 μm. (E) siRNA-mediated knock-down of CHIP has no effect on the steady-state protein levels of either wild-type or mutant ChAT. ChAT-expressing SN56 cells were co-transfected with 25 nM of either anti-CHIP siRNA or scramble-control siRNA for 72 h. Control cells were mock-transfected ( n = 4).

Article Snippet: Cells were washed with HBSS, formalin-fixed (4% paraformaldehyde in HBSS) for 15 min, permeabilized with 0.1% Triton X-100, blocked for 1 h in HBSS supplemented with 3% donkey serum, then finally incubated for 1 h with primary antibodies targeting ChAT (1:100; Chemicon, goat primary) together with either endogenous HSC70 (1:100; StressMarq, mouse primary), HSP90 (1:200; StressMarq, mouse primary) or CHIP (1:200; Santa Cruz, rabbit primary); all steps were performed at room temperature.

Techniques: Western Blot, Co-Immunoprecipitation Assay, Expressing, Mutagenesis, Transfection, Plasmid Preparation, In Situ, Proximity Ligation Assay, Labeling, Incubation, DNA Ligation, Amplification, Confocal Microscopy, Staining

RNAi screening of host factors related to EBOV-trVLP life cycle and further validation and analysis. (A) RNAi silencing analysis of host factors required for the EBOV trVLP life cycle. A 100 μl sample of opti-MEM medium containing 1.4 μl siRNA and 4.5 μl HiPerFect was placed in 24-well plates, and a cell suspension (400 μl) containing 1 × 10 5 cells was added to give a final siRNA concentration of 75 nM. After incubation for 48 h, cells were infected with trVLPs for another 48 h, total RNA was extracted, and the absolute quantity of EBOV RNA was measured using a EBOV nucleic acid test kit. All qRT-PCR experiments were performed in triplicate and repeated three times independently. Cells not transfected with siRNA but infected with trVLPs served as a blank control; cells transfected with isotype siRNA and infected with trVLPs served as a negative control. Eleven siRNAs targeting HSPA1A, HSP90AB1, ARFGAP1, ANXA5, YWHAZ, MAPK11, NTRK1, FLT4, GRP78, MEK2, and HSPA8 inhibited trVLP replication effectively. ∗ p < 0.05, ∗∗ p < 0.01. (B) Western blot analysis of each target protein after siRNA transfection. The 11 target proteins were all expressed at much lower levels following transfection with the relevant siRNA. Normal 293T cells and cells transfected with isotype siRNAs served as controls. (C) Characterization of selected networks of candidate host proteins that may be important for regulating the trVLP life cycle. Interactions of the 11 host proteins were assessed using the GeneMANIA interaction database, and their functions were evaluated in association with cytoplasmic vesicle membranes, mitochondrial membranes, mitochondria, antigen binding, the COP9 signalosome, and phospholipid binding.

Journal: Frontiers in Microbiology

Article Title: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements

doi: 10.3389/fmicb.2018.02724

Figure Lengend Snippet: RNAi screening of host factors related to EBOV-trVLP life cycle and further validation and analysis. (A) RNAi silencing analysis of host factors required for the EBOV trVLP life cycle. A 100 μl sample of opti-MEM medium containing 1.4 μl siRNA and 4.5 μl HiPerFect was placed in 24-well plates, and a cell suspension (400 μl) containing 1 × 10 5 cells was added to give a final siRNA concentration of 75 nM. After incubation for 48 h, cells were infected with trVLPs for another 48 h, total RNA was extracted, and the absolute quantity of EBOV RNA was measured using a EBOV nucleic acid test kit. All qRT-PCR experiments were performed in triplicate and repeated three times independently. Cells not transfected with siRNA but infected with trVLPs served as a blank control; cells transfected with isotype siRNA and infected with trVLPs served as a negative control. Eleven siRNAs targeting HSPA1A, HSP90AB1, ARFGAP1, ANXA5, YWHAZ, MAPK11, NTRK1, FLT4, GRP78, MEK2, and HSPA8 inhibited trVLP replication effectively. ∗ p < 0.05, ∗∗ p < 0.01. (B) Western blot analysis of each target protein after siRNA transfection. The 11 target proteins were all expressed at much lower levels following transfection with the relevant siRNA. Normal 293T cells and cells transfected with isotype siRNAs served as controls. (C) Characterization of selected networks of candidate host proteins that may be important for regulating the trVLP life cycle. Interactions of the 11 host proteins were assessed using the GeneMANIA interaction database, and their functions were evaluated in association with cytoplasmic vesicle membranes, mitochondrial membranes, mitochondria, antigen binding, the COP9 signalosome, and phospholipid binding.

Article Snippet: Antibodies recognizing 14-3-3 zeta/beta (YWHAZ; Cat# NB100-1964) and Hsc70 (HSPA8; Cat# NBP2-12880) were purchased from Novus Biologicals (Littleton, CO, United States).

Techniques: Biomarker Discovery, Suspension, Concentration Assay, Incubation, Infection, Quantitative RT-PCR, Transfection, Control, Negative Control, Western Blot, Binding Assay

Co-immunoprecipitation (Co-IP) and immunoblot analysis of interaction between target proteins and EBOV-trVLP glycoprotein (GP). (A) Co-IP and immunoblot analysis of EBOV trVLP GP. Extracts from HEK 293T cells infected with trVLPs were incubated with antibodies recognizing candidate host proteins plus Protein G beads; pulled-down proteins were detected by western blotting using anti-GP antibody. HSPA1A, MAPK11, NTRK1, GRP78, FLT4, HSPA8, MEK2, HSP90AB1, and YWHAZ interact with GP, whereas ARFGAP1, ANXA5, and isotype controls do not. Extracts incubated with Protein G beads without antibody, and antibodies mixed with Protein G beads and normal cell extracts without trVLPs served as controls. (B) Immunoblot analysis of the 11 target proteins before IP and (C) after IP. Samples were prepared as described above.

Journal: Frontiers in Microbiology

Article Title: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements

doi: 10.3389/fmicb.2018.02724

Figure Lengend Snippet: Co-immunoprecipitation (Co-IP) and immunoblot analysis of interaction between target proteins and EBOV-trVLP glycoprotein (GP). (A) Co-IP and immunoblot analysis of EBOV trVLP GP. Extracts from HEK 293T cells infected with trVLPs were incubated with antibodies recognizing candidate host proteins plus Protein G beads; pulled-down proteins were detected by western blotting using anti-GP antibody. HSPA1A, MAPK11, NTRK1, GRP78, FLT4, HSPA8, MEK2, HSP90AB1, and YWHAZ interact with GP, whereas ARFGAP1, ANXA5, and isotype controls do not. Extracts incubated with Protein G beads without antibody, and antibodies mixed with Protein G beads and normal cell extracts without trVLPs served as controls. (B) Immunoblot analysis of the 11 target proteins before IP and (C) after IP. Samples were prepared as described above.

Article Snippet: Antibodies recognizing 14-3-3 zeta/beta (YWHAZ; Cat# NB100-1964) and Hsc70 (HSPA8; Cat# NBP2-12880) were purchased from Novus Biologicals (Littleton, CO, United States).

Techniques: Immunoprecipitation, Co-Immunoprecipitation Assay, Western Blot, Infection, Incubation

Co-immunoprecipitation and immunoblot analysis of interaction between target proteins and EBOV-trVLP VP40. (A) Co-IP and immunoblot analysis of EBOV trVLP protein 40 (VP40). Extracts from HEK 293T cells infected with trVLPs were incubated with antibodies recognizing candidate host proteins plus Protein G beads, and pulled-down proteins were detected by western blotting using anti-VP40 antibody. HSP90AB1, ANXA5, HSPA1A, and GRP78 interact with VP40, whereas ARFGAP1, YWHAZ, MAPK11, NTRK1, FLT4, MEK2, HSPA8, and isotype controls do not. Extracts incubated with Protein G beads without antibody, and antibodies mixed with Protein G beads and normal cell extracts without trVLPs served as controls. (B) Immunoblot analysis of the 11 target proteins before IP and (C) after IP. Samples were treated as described above.

Journal: Frontiers in Microbiology

Article Title: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements

doi: 10.3389/fmicb.2018.02724

Figure Lengend Snippet: Co-immunoprecipitation and immunoblot analysis of interaction between target proteins and EBOV-trVLP VP40. (A) Co-IP and immunoblot analysis of EBOV trVLP protein 40 (VP40). Extracts from HEK 293T cells infected with trVLPs were incubated with antibodies recognizing candidate host proteins plus Protein G beads, and pulled-down proteins were detected by western blotting using anti-VP40 antibody. HSP90AB1, ANXA5, HSPA1A, and GRP78 interact with VP40, whereas ARFGAP1, YWHAZ, MAPK11, NTRK1, FLT4, MEK2, HSPA8, and isotype controls do not. Extracts incubated with Protein G beads without antibody, and antibodies mixed with Protein G beads and normal cell extracts without trVLPs served as controls. (B) Immunoblot analysis of the 11 target proteins before IP and (C) after IP. Samples were treated as described above.

Article Snippet: Antibodies recognizing 14-3-3 zeta/beta (YWHAZ; Cat# NB100-1964) and Hsc70 (HSPA8; Cat# NBP2-12880) were purchased from Novus Biologicals (Littleton, CO, United States).

Techniques: Immunoprecipitation, Western Blot, Co-Immunoprecipitation Assay, Infection, Incubation

Chromatin immunoprecipitation (ChIP) and DNA sequencing analysis of EBOV trVLP nucleic acids. Extracts from HEK 293T cells infected with trVLPs were processed and pulled down using a Chromatin IP Kit with antibodies recognizing candidate host proteins. Purified nucleic acids were amplified by qPCR, and products were sequenced by the Sanger chain termination method. Genotypes were attributed and compared with the Zaire ebolavirus sequence (GenBank No. KJ660348.2) using BioEdit software. Samples from HSP90AB1, ANXA5, ARFGAP1, FLT4, GRP78, HSPA1A, MEK2, NTRK1, and MAPK11 are consistent with sequences from EBOV, while HSPA8 and YWHAZ are not. Isotype negative controls were included.

Journal: Frontiers in Microbiology

Article Title: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements

doi: 10.3389/fmicb.2018.02724

Figure Lengend Snippet: Chromatin immunoprecipitation (ChIP) and DNA sequencing analysis of EBOV trVLP nucleic acids. Extracts from HEK 293T cells infected with trVLPs were processed and pulled down using a Chromatin IP Kit with antibodies recognizing candidate host proteins. Purified nucleic acids were amplified by qPCR, and products were sequenced by the Sanger chain termination method. Genotypes were attributed and compared with the Zaire ebolavirus sequence (GenBank No. KJ660348.2) using BioEdit software. Samples from HSP90AB1, ANXA5, ARFGAP1, FLT4, GRP78, HSPA1A, MEK2, NTRK1, and MAPK11 are consistent with sequences from EBOV, while HSPA8 and YWHAZ are not. Isotype negative controls were included.

Article Snippet: Antibodies recognizing 14-3-3 zeta/beta (YWHAZ; Cat# NB100-1964) and Hsc70 (HSPA8; Cat# NBP2-12880) were purchased from Novus Biologicals (Littleton, CO, United States).

Techniques: Chromatin Immunoprecipitation, DNA Sequencing, Infection, Purification, Amplification, Sequencing, Software